Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FAAH | O00519 | 3/20 | 0.83 |
| ▸ | MEN1 | O00255 | 1/20 | 0.83 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.83 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.83 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MAPT | P10636 | 1/20 | 0.49 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.46 |
| ▸ | PLA2G10 | O15496 | 1/20 | 0.46 |
| ▸ | CES2 | O00748 | 1/20 | 0.46 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
| ▸ | NOD1 | Q9Y239 | 1/20 | 0.46 |
| ▸ | PLA2G2C | Q5R387 | 1/20 | 0.46 |
| ▸ | ASAH2 | Q9NR71 | 1/20 | 0.45 |
| ▸ | CNR2 | P34972 | 1/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5737558 | 0.93 | FAAH (0.96) | FAAHMEN1MAPK1KMT2ADNM1 | |
| SCHEMBL1456458 | 0.91 | FAAH (1.00) | FAAHMEN1MAPK1KMT2ADNM1 | |
| SCHEMBL12459875 | 0.91 | FAAH (1.00) | FAAHMEN1MAPK1KMT2ADNM1 | |
| SCHEMBL19557778 | 0.91 | FAAH (1.00) | FAAHMEN1MAPK1KMT2ADNM1 | |
| SCHEMBL20143550 | 0.91 | FAAH (1.00) | FAAHMEN1MAPK1KMT2ADNM1 | |
| SCHEMBL4023787 | 0.91 | FAAH (1.00) | FAAHMEN1MAPK1KMT2ADNM1 | |
| SCHEMBL277126 | 0.91 | FAAH (1.00) | FAAHMEN1MAPK1KMT2ADNM1 | |
| SCHEMBL12377250 | 0.91 | FAAH (1.00) | FAAHMEN1MAPK1KMT2ADNM1 | |
| Hexadecanoic Acid Isopropylamide SCHEMBL1457147 | 0.91 | FAAH (1.00) | FAAHMEN1MAPK1KMT2ADNM1 | |
| SCHEMBL1456463 | 0.91 | FAAH (1.00) | FAAHMEN1MAPK1KMT2ADNM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 79 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101218028-B | A cell-based platform for high throughput screening | HONEYWELL INT INC | 2012-07-11 | — | — | CN | claimed |
| EP-1444201-A1 | 2-(3-SULFONYLAMINO-2-OXOPYRROLIDIN-1-YL)PROPANAMIDES AS FACTOR XA INHIBITORS | GLAXO GROUP LIMITED (GB) | 2004-08-11 | — | — | EP | claimed |
| WO-2003043981-A1 | 2-(3-SULFONYLAMINO-2-OXOPYRROLIDIN-1-YL)PROPANAMIDES AS FACTOR XA INHIBITORS | GLAXO GROUP LIMITED (GB) | 2003-05-30 | — | — | WO | claimed |
| CN-119930467-A | Preparation method of 2-cyano-2-propyl valerate and valproic acid | 湖南省湘中制药有限公司 | 2025-05-06 | — | — | CN | disclosed |
| CN-119213044-A | Resin, resin dispersion and resin composition | DNP精细化工股份有限公司 | 2024-12-27 | — | — | CN | disclosed |
| CN-119183469-A | Aqueous ink composition, recording method, method for producing recorded matter, and inkjet recording device | DNP精细化工股份有限公司 | 2024-12-24 | — | — | CN | disclosed |
| CN-118302299-A | Maintenance liquid, method for producing maintenance liquid, method for maintaining ink jet recording apparatus, and ink jet recording apparatus | DNP精细化工股份有限公司 | 2024-07-05 | — | — | CN | disclosed |
| EP-4364951-A1 | OVERCOAT INK AND INK SET CONTAINING SAME | DNP Fine Chemicals Co., Ltd. (JP) | 2024-05-08 | — | — | EP | disclosed |
| WO-2024004899-A1 | RESIN AND RESIN COMPOSITION | 株式会社ＤＮＰファインケミカル | 2024-01-04 | — | — | WO | disclosed |
| US-20230331750-A1 | Preparation Method for Glufosinate | LIER CHEMICAL CO., LTD. (CN) | 2023-10-19 | — | — | US | disclosed |
| WO-2023192961-A2 | LIGAND-PAYLOAD CONJUGATES | PYXIS ONCOLOGY, INC. (US) | 2023-10-05 | — | — | WO | disclosed |
| US-5864043-A | CARDIOVASCULAR DISORDERS AND ANGIOTENSIN ANTAGONIST | KARL THOMAE GMBH (DE) | 1999-01-26 | — | — | US | disclosed |
| WO-1997029748-A1 | SUBSTITUTED BIPHENYL ISOXAZOLE SULFONAMIDES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-08-21 | — | — | WO | disclosed |
| CN-1153177-A | 13-substituted milbemycin 5-oxime derivatives their preparation and their use against insects and other pests | SANKYO CO (JP) | 1997-07-02 | — | — | CN | disclosed |
| US-5614519-A | (1-(2,3 or 4-N-morpholinoalkyl)-imidazol-4-yl)-benizimidazol-1-yl-methyl]-biphenyls useful as angiotensin-II antagonists | KARL THOMAE GMBH (DE) | 1997-03-25 | — | — | US | disclosed |
| US-5602127-A | ADMINISTERING TO TREAT HYPERTENSION | KARL THOMAE GMBH (DE) | 1997-02-11 | — | — | US | disclosed |
| US-5594003-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-14 | — | — | US | disclosed |
| US-5591762-A | HYPOTENSIVE AGENTS | DR. KARL THOMAE GMBH (DE) | 1997-01-07 | — | — | US | disclosed |
| US-5541229-A | ANGIOITENSIN II ANTAGONIST AS HYPOTENSIVE AGENTS, ANTIISCHEMIC AGENTS AND CARDIOVASCULAR DISORDERS | DR. KARL THOMAE GMBH (DE) | 1996-07-30 | — | — | US | disclosed |
| US-5459147-A | Angeotensin-antagonistic effects; hypotensive, antiischemic, and antidiabetic agents, treating glaucoma | DR. KARL THOMAE GMBH (DE) | 1995-10-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230331750-A1 | Preparation Method for Glufosinate | GLUL, ASNS, GDA | FAAH 3270/4885MEN1 2164/4885MAPK1 3993/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.